Insider Buying: American Vanguard Co. (NYSE:AVD) Director Acquires 8,500 Shares of Stock

American Vanguard Co. (NYSE:AVDGet Free Report) Director Steven D. Macicek acquired 8,500 shares of the business’s stock in a transaction on Wednesday, May 15th. The shares were purchased at an average price of $9.01 per share, with a total value of $76,585.00. Following the completion of the purchase, the director now owns 10,044 shares in the company, valued at approximately $90,496.44. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

American Vanguard Trading Up 3.9 %

NYSE AVD opened at $9.10 on Friday. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.29 and a quick ratio of 1.12. The stock has a market capitalization of $254.71 million, a P/E ratio of 35.00 and a beta of 1.05. The firm’s 50-day moving average is $11.61 and its two-hundred day moving average is $10.79. American Vanguard Co. has a 12 month low of $8.41 and a 12 month high of $18.38.

American Vanguard (NYSE:AVDGet Free Report) last announced its earnings results on Thursday, May 9th. The basic materials company reported $0.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.08 by $0.01. The company had revenue of $135.14 million for the quarter, compared to analyst estimates of $141.20 million. American Vanguard had a return on equity of 2.20% and a net margin of 1.22%. During the same quarter in the previous year, the company earned $0.07 earnings per share. On average, sell-side analysts anticipate that American Vanguard Co. will post 0.44 earnings per share for the current year.

American Vanguard Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, April 10th. Stockholders of record on Wednesday, March 27th were paid a $0.03 dividend. This represents a $0.12 annualized dividend and a dividend yield of 1.32%. The ex-dividend date was Tuesday, March 26th. American Vanguard’s payout ratio is 46.15%.

Institutional Trading of American Vanguard

Large investors have recently modified their holdings of the stock. CWM LLC increased its holdings in American Vanguard by 492.4% during the 4th quarter. CWM LLC now owns 2,340 shares of the basic materials company’s stock worth $26,000 after purchasing an additional 1,945 shares during the period. Gladius Capital Management LP acquired a new position in shares of American Vanguard during the fourth quarter worth about $37,000. Tower Research Capital LLC TRC increased its stake in shares of American Vanguard by 240.5% during the fourth quarter. Tower Research Capital LLC TRC now owns 6,885 shares of the basic materials company’s stock worth $76,000 after buying an additional 4,863 shares during the period. Bfsg LLC purchased a new stake in shares of American Vanguard during the fourth quarter worth approximately $98,000. Finally, WINTON GROUP Ltd acquired a new stake in American Vanguard in the third quarter valued at approximately $119,000. Hedge funds and other institutional investors own 79.04% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently commented on AVD shares. cut American Vanguard from a “buy” rating to a “hold” rating in a research report on Friday, May 10th. Loop Capital upped their target price on shares of American Vanguard from $19.00 to $20.00 and gave the stock a “buy” rating in a report on Monday, April 15th. Roth Capital reiterated a “buy” rating on shares of American Vanguard in a research report on Wednesday, January 31st. Finally, Roth Mkm upped their price objective on shares of American Vanguard from $13.00 to $16.00 and gave the company a “buy” rating in a research note on Friday, March 15th. One research analyst has rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat, American Vanguard has an average rating of “Moderate Buy” and an average target price of $18.00.

Get Our Latest Analysis on American Vanguard

American Vanguard Company Profile

(Get Free Report)

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.

Featured Stories

Insider Buying and Selling by Quarter for American Vanguard (NYSE:AVD)

Receive News & Ratings for American Vanguard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard and related companies with's FREE daily email newsletter.